VITASPRING BIOMEDICAL CO. LTD.
10-K December 1, 2025
Key Highlights
- The company is facing challenges with timely SEC filings and has undertaken sign...
- Restatements triggered a review of executive incentive-based compensation, with ...
- Classified as a Smaller reporting and Emerging growth company, it submitted inte...
Read Analysis
🤖 AI Generated